Telefónica and IQM to Provide the Community of Madrid With Its First Quantum Computer to Drive the Development of Industry Use Cases Across the Region

Telefónica and IQM to Provide the Community of Madrid With Its First Quantum Computer to Drive the Development of Industry Use Cases Across the Region

The IQM Spark quantum computer, to be located at the Universidad Politécnica de Madrid, will be the third system deployed in Spain through the collaboration between IQM and Telefónica, positioning the region as a benchmark for digital innovation.

MADRID, Spain & ESPOO, Finland–(BUSINESS WIRE)–
Telefónica and IQM Quantum Computers, a global leader in superconducting quantum computing, have joined forces to deploy the first quantum computer in the Community of Madrid. The initiative will strengthen the region’s scientific and technological capabilities, while driving the development of real-world cases for companies across the Community of Madrid.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022980581/en/

IQM and Telefónica are bringing an IQM Spark quantum computer to Universidad Politécnica de Madrid, giving researchers, students and industry across the Community of Madrid hands-on access to real quantum hardware.

IQM and Telefónica are bringing an IQM Spark quantum computer to Universidad Politécnica de Madrid, giving researchers, students and industry across the Community of Madrid hands-on access to real quantum hardware.

The IQM Spark quantum computer, an all-in-one solution specifically designed for research, education and early-stage development, will be installed at the Universidad Politécnica de Madrid before the end of 2026. It will enable universities, hospitals, research centers and start-ups, direct access to real quantum hardware to develop and test quantum algorithms and build the expertise needed to explore future use cases.

This will be the first quantum computer of its kind in the Community of Madrid, significantly increasing the region’s capacity to develop quantum capabilities locally and through hands-on experience. The computer will join the other two quantum computers provided by Telefónica and IQM to CESGA (Galician Supercomputing Centre).

Once the new quantum computer is operational, the Community of Madrid will have greater capabilities to foster the creation of its own quantum ecosystem, bringing together all stakeholders involved in developing real-world use cases that deliver direct benefits to local industry. This ecosystem will help attract talent and strengthen Madrid’s position as a leading hub for advanced digital innovation, while also contributing to the development of European technological sovereignty.

Borja Ochoa, non-executive Chairman of Telefónica España and CEO of B2B, said: “This project marks another step forward in Telefónica’s close collaboration with the Community of Madrid in the deployment of quantum technologies, both in networks and in the encryption and protection of critical data in particularly sensitive sectors such as healthcare and security, and now also through the research opportunities offered by quantum computing. In line with its goal of becoming the best gateway to digital technologies for citizens, businesses and public administrations, Telefónica is the first operator in Spain to offer communications between data centers protected by the new post-quantum cryptography standards. Our company is also helping to build a national ecosystem by developing technologies and communications, specialized centers and strategic projects ranging from the development of cancer treatments to reducing the use of cardboard by packaging companies.”

Jan Goetz, CEO and Co-founder of IQM Quantum Computers, said: “By investing in its own quantum computer, the Community of Madrid is creating an infrastructure that will enable its researchers, students and industries to grow their capabilities over the long term. Quantum computing becomes truly valuable when it moves beyond remote laboratory environments and is placed directly in the hands of those working closest to the real-world challenges it can help address. This deal represents an important step forward for Madrid and for Europe in its ambition to lead the development of quantum computing.”

This project further expands IQM’s growing international footprint, with full-stack quantum computers already deployed across Europe, Asia and North America, including computers supplied to some of the world´s leading supercomputing centers. IQM is also driving the adoption of quantum computing in areas such as research, materials science, financial modeling and other fields, by giving end users direct ownership of the infrastructure needed to turn experimentation into real-world, high-impact applications.

About IQM Quantum Computers

IQM Quantum Computers (Nasdaq: IQMX) is a global leader in superconducting quantum computers, delivering full-stack quantum computers and cloud platform access to enterprises, research institutions, universities, high-performance computing centers, and national laboratories worldwide. IQM’s on-premises deployment model gives customers direct ownership and control of their quantum infrastructure. Founded in 2018 and headquartered in Finland, with major operations in Munich, IQM employs over 450 people and operates across Europe, Asia, and North America. IQM is the first publicly listed European quantum company on Nasdaq Stock Market.

About Telefónica

Telefónica is one of the world’s leading telecommunications service providers. The company is committed to becoming the leading gateway to digital technologies for citizens, businesses and public administrations, contributing to economic and social progress in the markets where it operates.

Telefónica provides fixed and mobile connectivity services, together with a broad portfolio of digital solutions for residential and business customers. With more than 299.8 million accesses, the company focuses its operations on its four core markets: Spain, Brazil, Germany and the United Kingdom.

IQM Media contact

[email protected]

KEYWORDS: United States Finland Canada North America Spain Europe

INDUSTRY KEYWORDS: Technology Hardware Semiconductor Telecommunications

MEDIA:

Photo
Photo
IQM and Telefónica are bringing an IQM Spark quantum computer to Universidad Politécnica de Madrid, giving researchers, students and industry across the Community of Madrid hands-on access to real quantum hardware.
Logo
Logo

Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01

  • EVX-01 induced an immune response in all patients in the trial with 89% of the vaccine neoantigens generating potent specific T-cell responses 
  • Three-year data from the EVX-01 phase 2 trial in patients with advanced melanoma to be presented at the ESMO 2026 Congress supplementing very convincing two-year data from the trial
  • The data will be presented at a poster session on October 24, 2026, followed by a webinar on October 29, 2026, providing further insights into the findings

COPENHAGEN, Denmark, October 23, 2026 – Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, announces new three-year immune and clinical outcome data for personalized cancer vaccine EVX-01 in patients with advanced melanoma.

The data demonstrates EVX-01 inducing an immune response in all patients, with 89% of its personalised vaccine antigen targets inducing a tumor-specific immune response in treated patients. Further, sustained T-cell responses were observed, with preserved magnitude and breadth of the specific immune response, during the third year of the phase 2 trial in which EVX-01 was administered as monotherapy.

The new data also shows that all patients maintained their clinical response observed at two-year follow-up with no tumor progression observed through the third year of EVX-01 treatment alone. The data will be presented in a poster presentation at the European Society for Medical Oncology (ESMO) Congress 2026 held in Madrid, Spain, tomorrow.

The new findings supplement the unprecedented two-year data presented at ESMO in 2025, showing a 75% Objective Response Rate with 25% of patients obtaining a complete response.

“We are delighted to announce yet another set of strong immune and clinical data for EVX-01. The 89% target precision documented in the trial is another confirmation that AI-Immunology™ identifies and selects the most therapeutically relevant vaccine targets. Thus, the new data supports both EVX-01 as a promising personalized cancer vaccine and our platform as a validated technology for discovery and design of novel treatments,” says Birgitte Rønø, CSO and COO of Evaxion.

“What makes these three-year findings particularly compelling is not only the durability of clinical responses, but also the sustained strength and breadth of vaccine-induced T-cell immunity. These results offer an exciting glimpse into the future of precision oncology, where we can harness the unique biology of each patient’s tumor to train the immune system to recognize and target cancer with remarkable specificity. The prospect of translating this highly personalized immune response into long-lasting disease control represents an important step forward and offers renewed hope for patients facing advanced cancer“, says Professor Muhammad Adnan Khattak, Oncology, One Clinical Research, Hollywood Private Hospital & Edith Cowan University, Perth, Australia, key opinion leader and one of the trial’s investigators.

Building on convincing two-year results
In addition to promising response rates, the two-year data from the trial also showed a durable clinical benefit, with 92% of patients still responding at two years of follow-up and no relapses observed.

54% of patients had a deepened response following initiation of EVX-01 treatment, improving from stable disease or partial response to partial or complete response. Tumor reduction (target lesions) was observed in 15 out of the 16 patients enrolled in the trial.

EVX-01 induced an immune response in all patients, with 86% of the vaccine neoantigens generating potent specific T-cell responses as measured at the two-year follow-up. Analyses of additional samples collected during the one-year extension phase further increased this neoantigen hit-rate to 89%.

Evaxion maintains a cash runway extending well into the second half of 2027.

About the phase 2 trial
The phase 2 trial investigated EVX-01 in patients with advanced melanoma. Each patient enrolled in the trial received a unique vaccine designed and manufactured based on their individual biology.

In the first two-years, patients received EVX-01 in combination with MSD’s (Merck & Co., Inc., Rahway, NJ, USA) anti-PD-1 therapy, KEYTRUDA® (pembrolizumab). KEYTRUDA® is a registered trademark of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.

Six out of 12 responders continued in the trial’s one-year extension, where they received EVX-01 as stand-alone therapy.

Webinar on October 29, 2026
Evaxion will host a webinar featuring key opinion leader and trial investigator, Professor Muhammad Adnan Khattak, on October 29, 2026, at 15.30 CET/10.30am EDT.

The webinar can be attended through registration via this link.

In the webinar, Professor Khattak will present the three-year clinical and immune data from the EVX-01 phase 2 trial in patients with advanced melanoma. The presentation will highlight clinical outcomes, durability of responses and vaccine-induced immune responses following three years of follow-up. The presentation will be followed by a Q&A session, with participants encouraged to submit questions.

Poster presentation details

  • Poster title: EVX-01, a personalized cancer vaccine, induces sustained T-cell responses and durable disease control in advanced melanoma after three-year of follow-up
  • Presentation#: 2006P
  • Location: Poster Area – Hall 5
  • Topic: Investigational immunotherapy
  • Date/Time: October 24, 2026, at 12:00 – 12:45 CET
  • Presenter: Professor Muhammad Adnan Khattak, Director, Oncology, One Clinical Research, Hollywood Private Hospital & Edith Cowan University, Perth, WA, Australia

About EVX-01
EVX-01 is a personalized peptide-based cancer vaccine intended for first-line treatment of multiple advanced solid cancer tumors. It is currently being evaluated as a treatment of advanced melanoma and is Evaxion’s lead clinical asset.

Designed with our AI-Immunology™ platform, EVX-01 is tailored to target the unique tumor profile and immune characteristics of each patient. It engages the patient’s immune system to fight off cancer by mounting a targeted response against tumor-specific neoantigens.

Contact information
Evaxion A/S
Mads Kronborg
Vice President, Investor Relations & Communication
+45 53 54 82 96
[email protected]

About Evaxion
Evaxion is a pioneering clinical-stage TechBio company based upon its proprietary, clinically validated and scalable AI platform, AI-Immunology™. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer as well as infectious and autoimmune diseases.

With AI-Immunology™ we conduct rapid, efficient and high-quality target discovery, drug design and development. Our team of +40 experts covers the entire value chain from target discovery to clinical development.

We have developed a pipeline of both personalized and off-the-shelf cancer vaccine candidates as well as prophylactic vaccine candidates for infectious diseases. All our candidates address high unmet medical needs, reflecting our commitment to transforming patients’ lives by providing innovative and targeted treatment options.

For more information about Evaxion, AI-Immunology™ and our pipeline, please visit our website. 

Forward-looking statement
This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The words “target,” “believe,” “expect,” “hope,” “aim,” “intend,” “may,” “might,” “anticipate,” “contemplate,” “continue,” “estimate,” “plan,” “potential,” “predict,” “project,” “will,” “can have,” “likely,” “should,” “would,” “could,” and other words and terms of similar meaning identify forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements as a result of various factors, including, but not limited to, risks related to: our financial condition and need for additional capital; our development work; cost and success of our product development activities and preclinical and clinical trials; commercializing any approved pharmaceutical product developed using our AI platform technology, including the rate and degree of market acceptance of our product candidates; our dependence on third parties including for conduct of clinical testing and product manufacture; our inability to enter into partnerships; government regulation; protection of our intellectual property rights; employee matters and managing growth; our ADSs and ordinary shares, the impact of international economic, political, legal, compliance, social and business factors, including inflation, and the effects on our business from other significant geopolitical and macro-economic events; and other uncertainties affecting our business operations and financial condition. For a further discussion of these risks, please refer to the risk factors included in our most recent Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission (SEC), which are available at www.sec.gov. We do not assume any obligation to update any forward-looking statements except as required by law. 



Zana Möhlmann from Singapore crowned Global Bartender of the Year 2026 at the prestigious Diageo World Class Global Finals event in Edinburgh

Top bartenders from 49 countries competed in Scotland for the coveted title

EDINBURGH, United Kingdom, Oct. 22, 2026 (GLOBE NEWSWIRE) — Zana Möhlmann from Singapore has been crowned Diageo World Class Global Bartender of the Year 2026 at the world’s biggest cocktail competition, taking top place among finalists from six continents.

Möhlmann of East47 at Conrad Singapore Orchard combined technical mastery and creative flair with the warm, intuitive hospitality that defines a truly world class bartender.

Originally from the Netherlands, she found bartending on a gap year in Asia and trained in Amsterdam’s bars. She then joined the opening team of Ryan Chetiyawardana’s Super Lyan, rising to Head Bartender. She spent months refining every serve in preparation for the Global Finals, dedication that paid off last night in Edinburgh.

Alongside the title, Zana will represent Diageo and its brands in a year-long opportunity to showcase her bartending skills around the world and, for the first time, this year’s Global Bartender of the Year will partner with Diageo to create a ready-to-drink cocktail that will launch in multiple markets next year. The title also includes an all-expenses trip to the 2027 World Class Global Final.

A 16-strong international judging panel of well-known leading figures from the global bar industry, including Ago Perrone of London’s Connaught Bar, Monica Berg of Tayēr + Elementary, and Lorenzo Antinori of Hong Kong’s Bar Leone (recently named The World’s Best Bar at The 50 Best Bars 2026, for the second consecutive year) judged competitors across a series of live brand challenges (challenges listed in notes to editors, below).

Speaking on behalf of the judging panel, Ago Perrone said:

“My fellow judges and I have been impressed by the dedication and the efforts that have gone into each creation this year. It’s always so inspiring to watch the next generation at work, even more so Zana. Zana won us over thanks to the imagination, commitment and real heart she put into the challenges showing the warmth of a true host. And that’s what really makes a World Class bartender.”

The World Class programme showcases Diageo’s commitment to a vibrant hospitality sector, the on-trade and its customers, while creating a space to share insights on the latest drinking trends. Since 2009, the programme has celebrated and nurtured the careers of over 500,000 bartenders.

Kevin Delaney, Global Head of World Class, said:

“World Class is the ultimate toast to the beating heart of the hospitality industry: rockstar bartenders pushing the boundaries of their creativity and skill through competition – hosting tirelessly, serving responsibly and setting the trends we’ll all experience in the future. It’s a program dedicated to the trade – because when bartenders flourish, the experience is enhanced for everyone. We are delighted to welcome Zana into the Diageo World Class Hall of Fame.”

This year, the Global Finals were marked with Scotland Served, a World Class Festival transforming more than 400 venues across the country into destinations for exploration into Scotch Whisky, showcasing a new generation of Scotch cocktails from Johnnie Walker and The Singleton.

Celebrating both the World Class win and her 29th birthday on the same night, Zana Möhlmann World Class Global Bartender of the Year 2026, said:

“It’s unbelievable. I don’t think I know how to feel yet. I’d let myself imagine this moment a little, but I was almost scared to, and there were moments I didn’t think I would win. I’ve never been so happy, or so surprised.”

With the Global Finals on Scottish soil, the judging panel also included Scottish talent, including Iain McPherson of Edinburgh’s award-winning Panda & Sons; Andy Gemmell, owner of The Gate pub in Glasgow; and Kaitlin Wilkes, co-founder of The Ada Coleman Project.

The bartender challenges included:

  • ‘Community Spirit’, Ketel One Vodka high-stakes relay of precision and speed
  • ‘The Slow Train’, an intimate cocktail and food pairing featuring The Singleton Whisky aboard a private train to the brand’s Glen Ord Distillery
  • ‘Under Pressure’, reimagining Don Julio Tequila as a ready-to-drink, carbonated serve with original label artwork
  • ‘Iconology’, a head-turning Tanqueray No. TEN Gin cocktail built to command a room
  • ‘Fast Forward’, a three-drink Johnnie Walker Black Label mixtape flight, each cocktail paired with a music track from [HIS/HER/THEIR] bartending journey.

Assets available: Images of winner, spokesperson for interviews.

WINNER’S BIO

Zana Möhlmann is the Beverage Manager of Manhattan and East47 at Conrad Singapore Orchard. At Manhattan, she builds upon the fvenue’s celebrated legacy, honouring the Golden Age of cocktails while evolving its story through innovative menu concepts such as Seasons of Manhattan. At East47, she champions a more experimental approach, pushing creative boundaries while maintaining a relentless focus on flavour and guest experience.

Previously Manhattan’s Head Bartender, Zana played a key role in shaping the bar’s creative identity while fostering a culture of collaboration, mentorship, and inclusivity. Today, she oversees the beverage vision for both venues, balancing heritage with innovation and strengthening Manhattan’s global reputation while establishing East47 as an emerging destination on the international cocktail scene.

Originally from the Netherlands, Zana discovered bartending during a gap year travelling through Asia. She refined her craft in acclaimed Amsterdam bars before joining the opening team of Super Lyan by Ryan Chetiyawardana, rising to Head Bartender.

Her achievements include being crowned in several bartending competitions. Her work has also been featured in Difford’s Guide, The Spirits Business, and Drink Magazine Asia. Through creativity, leadership, and an inclusive approach, Zana continues to shape exceptional bar experiences and inspire the global bartending community.

ABOUT WORLD CLASS

World Class is on a mission to inspire people to drink better and create unforgettable experiences in the process. Whether at home or in a bar, World Class encourages consumers to think and care about what, where and how they drink, and in doing so, discover the best of cocktail culture.

World Class has supported, trained and inspired over 500,000 bartenders across the globe over the past seventeen years, while partnering them with the world’s finest spirits. It is the authority on the global drinks industry for information on the latest drinks, trends, cocktail recipes and industry insight.

ABOUT DIAGEO

Diageo is a global leader in beverage alcohol with an outstanding collection of brands across spirits and beer categories. These brands include Johnnie Walker, Crown Royal, J&B and Buchanan’s whiskies, Smirnoff and Ketel One vodkas, Captain Morgan, Baileys, Don Julio, Tanqueray and Guinness.

Diageo is a global company, and our products are sold in nearly 180 countries around the world. The company is listed on both the London Stock Exchange (DGE) and the New York Stock Exchange (DEO). For more information about Diageo, our people, our brands, and performance, visit us at www.diageo.com. Visit Diageo’s global responsible drinking resource, www.DRINKiQ.com for information, initiatives, and ways to share best practice.

Crafting iconic drinks chosen for life’s moments.

Photos accompanying this announcement are available at https://www.globenewswire.com/NewsRoom/AttachmentNg/645d55a6-8d78-480d-af7c-a3e6f9db2923

https://www.globenewswire.com/NewsRoom/AttachmentNg/213488d3-fc52-4050-adcc-19ce8a14d6e4

https://www.globenewswire.com/NewsRoom/AttachmentNg/46ca3f3f-83bf-453f-8ec6-564d37b77deb

https://www.globenewswire.com/NewsRoom/AttachmentNg/79c50a09-5395-4594-8027-d7e2056babde

https://www.globenewswire.com/NewsRoom/AttachmentNg/564fa8b1-813a-4e74-9c14-23a7b3dad978



For more information, please contact [email protected]

Zai Lab Announces $250 Million Private Placement

Zai Lab Announces $250 Million Private Placement

SHANGHAI & CAMBRIDGE, Mass.–(BUSINESS WIRE)–
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) an innovation-driven, global biopharma company, today announced that it has entered into a securities purchase agreement for the sale of 11,340,000 American Depositary Shares (“ADSs”), each representing ten ordinary shares of the Company, to certain investors in a private investment in public equity (“PIPE”) financing. The purchase price of each ADS is $22.04. Gross proceeds from the PIPE financing are expected to be approximately $250 million, before deducting placement agent fees and other offering expenses. The PIPE financing is expected to close on or about October 27, 2026, subject to customary closing conditions.

The financing is led by TCGX and includes participation from other new and existing investors including abrdn World Healthcare Fund, ADAR1 Capital Management, Balyasny Asset Management, Cormorant Asset Management, Frazier Life Sciences, RA Capital Management, RTW Investments, Sirenia Capital Management LP, Wellington Management, and Woodline Partners LP.

Zai Lab intends to use the net proceeds from the PIPE financing primarily to support the continued global development of zocilurtatug pelitecan (zoci), the Company’s Delta-like ligand 3 (DLL3)-targeting antibody-drug conjugate (ADC).

Leerink Partners is acting as exclusive placement agent for the PIPE financing. Ropes & Gray is acting as legal advisor to Zai Lab.

The sale and issuance of the foregoing ADSs are being made in a transaction not involving a public offering and have not been registered under the Securities Act of 1933, as amended (the “Securities Act”). The ADSs being issued in the PIPE may not be offered or sold in the United States absent registration or pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws. The Company has agreed to file a registration statement with the Securities and Exchange Commission covering the resale of the ADSs acquired by the investors in the Private Placement.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Zai Lab

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. Our goal is to leverage our competencies and resources to positively impact human health.

Zai Lab Forward-Looking Statements

This press release contains forward-looking statements relating to our future expectations, plans, and prospects, for Zai Lab, including, without limitation, statements relating to our prospects and plans for developing and commercializing zoci and related timing, the potential treatment of extensive-stage small cell lung cancer (ES-SCLC), our ability to successfully complete the PIPE indicated and with terms and conditions satisfactory to us, the expected closing of the PIPE and the expected use of proceeds from the PIPE. All statements, other than statements of historical fact, included in this press release are forward-looking statements, and can be identified by words such as “aim,” “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “goal,” “intend,” “may,” “plan,” “possible,” “potential,” “will,” “would,” and other similar expressions. Such statements constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and U.S. federal securities laws. There can be no assurance that we will be able to complete the PIPE on the anticipated terms, or at all. Forward-looking statements are not guarantees or assurances of future performance. Forward-looking statements are based on our expectations and assumptions as of the date of this press release and are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements. We may not actually achieve the plans, carry out the intentions or meet the expectations or projections disclosed in our forward-looking statements, and you should not place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by forward-looking statements as a result of various important factors, including but not limited to (1) our ability to successfully commercialize and generate revenue from our approved products, (2) our ability to obtain funding for our operations and business initiatives, (3) the results of our clinical and pre-clinical development of our product candidates, (4) the content and timing of decisions made by the relevant regulatory authorities regarding regulatory approvals of our product candidates, (5) risks related to doing business in China, and (6) other factors identified in our most recent annual and quarterly reports and in other reports we have filed with the U.S. Securities and Exchange Commission (SEC). We anticipate that subsequent events and developments will cause our expectations and assumptions to change, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required by law. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

For more information, please contact:


Investor Relations:

Christine Chiou / Cyan Liu

+1 (917) 886-6929 / +86 195 3130 8895

[email protected] / [email protected]

Media:

Shaun Maccoun / Xiaoyu Chen

+1 (857) 270-8854 / +86 185 0015 5011

[email protected]/ [email protected]

KEYWORDS: Massachusetts China United States North America Asia Pacific

INDUSTRY KEYWORDS: Science Neurology Biotechnology Research Pharmaceutical Oncology Health Infectious Diseases

MEDIA:

Logo
Logo

Sensata Technologies Board Approves Q4 2026 Dividend of $0.12 per share

Sensata Technologies Board Approves Q4 2026 Dividend of $0.12 per share

SWINDON, United Kingdom–(BUSINESS WIRE)–
Sensata Technologies (NYSE: ST) today announced that its Board of Directors approved a quarterly dividend in the amount of $0.12 per share. The Company will pay this fourth quarter 2026 dividend on November 25, 2026, to shareholders of record as of November 11, 2026.

About Sensata Technologies

Sensata Technologies is a global industrial technology company striving to create a safer, cleaner, more efficient and electrified world. Through its broad portfolio of mission-critical sensors, electrical protection components and sensor-rich solutions, Sensata helps its customers address increasingly complex engineering and operating performance requirements. With more than 16,000 employees and global operations in 13 countries, Sensata serves customers in the automotive, industrial, and aerospace, defense and commercial equipment markets. Learn more at www.sensata.com and follow Sensata on LinkedIn, Facebook, X and Instagram.

Media & Investor Contact:

James Entwistle

+1 (508) 954-1561

[email protected]

[email protected]

KEYWORDS: United Kingdom Europe

INDUSTRY KEYWORDS: Automotive Manufacturing Automotive Technology Manufacturing Trucking Semiconductor Other Energy Transport General Automotive Energy Engineering

MEDIA:

Logo
Logo

Foremost to Form Joint Ventures with Denison for GR and Blackwing Properties and to Issue Warrants at a Significant Premium

Foremost to receive proceeds of $650,000, retain 20% in GR and Blackwing properties, and will have a 6-month grace period for initial JV expenditures

VANCOUVER, British Columbia, Oct. 22, 2026 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”) is pleased to report that it has entered into an agreement with Denison Mines Corp. (“Denison”) to sell a 31% interest in the GR and Blackwing properties (together the “Properties”), form two exploration joint ventures (“JVs”), and issue 1,031,191 share purchase warrants (the “Warrants”) in exchange for total consideration of $650,000 (collectively, the “Transaction”). The warrants will have an exercise price of $1.80 per warrant share, which represents over a 175% premium to Foremost’s closing share price on October 22, 2026, and will have a 5-year term.  

David Cates, Interim CEO of Foremost commented, “The GR and Blackwing properties are located in the northwestern portion of the Athabasca Basin region and are situated along the Grease River shear zone and the Black Bay fault respectively – both of which are geologically prospective areas that have historically been subject to little or no exploration. While these Properties have the potential to become a new area of exploration focus in the region, the scale of the Properties and the annual work expenditures required to keep the claims in good standing are significant. As a result, forming JVs with Denison is an ideal arrangement for Foremost, whereby Foremost retains exposure to potential future exploration success without having to carry the full cost of exploring this district-scale area.”

Completion of the Transaction is expected to take place on or about November 2, 2026, subject to receipt of all regulatory and stock exchange approvals and other customary closing conditions.

GR & Blackwing Highlights

  • Foremost and Denison agree to form two exploration JVs on closing, where Foremost retains a 20%-ownership interest in each of the Properties.
  • The GR property is comprised of 16 mineral claims covering 78,585 hectares, and the Blackwing property is comprised of 3 mineral claims covering 12,627 hectares (See Figure 1).
  • Denison will be responsible for funding 80% of future expenditures, pursuant to the JV agreements, and commits to either carry out geophysical studies or make deficiency deposits to maintain the Properties until at least January 4, 2028 (the “Initial Expenditures”).
  • Foremost expects Denison will carry out geophysical studies within the next 12 months to further define the exploration potential of the Properties and generate future drill targets.
  • Foremost retains an option to decide within 6 months of the earlier of completion of the initial geophysical surveys or the date of the last of the Initial Expenditures whether it (i) funds its share of Initial Expenditures or (ii) dilutes its ownership pursuant to the terms of the JVs. 



Figure 1. GR & Blackwing Properties

Warrant Terms

  • On closing, Foremost will issue 1,031,191 Warrants with an exercise price of $1.80 per warrant share and a term of 5 years (the “Term”).
  • Exercise price of $1.80 represents over a 175% premium to Foremost’s closing share price of $0.64 on October 22, 2026.
  • The number of warrants exercisable by Denison at any time is limited to such number of Warrants that, if exercised, would not result in Denison’s ownership of Foremost exceeding 19.95% (the “Ownership Cap”).
  • At maturity, if exercise of any remaining Warrants would result in the holder exceeding the Ownership Cap, then Foremost will either (a) apply for and obtain an extension of the Term of the Warrants for such duration as may be approved by the Canadian Securities Exchange, or (b) purchase from the holder any remaining Warrants not exercisable due to the Ownership Cap based on the differential between the exercise price and the current market price for each warrant share.
  • The Warrants will be subject to a four-month hold period and thereafter will be transferable.

Amended & Restated Option Agreement

  • The Option Agreement entered into between Denison and Foremost on September 23, 2024 (the “Original Option Agreement”) included 10 properties and will be amended and restated (the “A&R Option Agreement”) on closing to exclude the GR & Blackwing Properties such that Foremost will no longer have any right to increase its ownership interest in those two Properties.
  • Accordingly, any subsequent expenditures incurred by Foremost in connection with the GR and Blackwing Properties will be governed by the applicable JV agreements and will not count towards satisfaction of Option Tranche 3 under, and as defined in, the A&R Option Agreement.
  • The A&R Option Agreement will preserve Foremost’s right to complete Option Tranche 3 and earn an additional 19% interest (for an aggregate interest of 70%) in 7 of the remaining 8 properties under option from Denison and a minimum 51% interest in Hatchet Lake, by (i) completing $12.0 million in eligible exploration expenditure on the remaining 8 properties by July 9, 2029, and (ii) payment to Denison of $2.5 million in additional consideration in a combination of cash or common shares of Foremost.
  • The full details of the A&R Option Agreement will be available under Foremost’s profile on SEDAR+ at www.sedarplus.ca.

National Investor Relations & Television Campaign

The Company has extended its previous engagement with RedChip Companies Inc. (“RedChip”) of 31 E Horatio Ave, Suite #100, Maitland, FL 32751 (email: [email protected]) to provide marketing services from mid-October 2026 to April 2027 at a cost of USD$11,000 per month.

Additionally, RedChip has secured a two-week national television campaign for Foremost, featuring a 30-second advertisement on CNBC, Fox Business, Bloomberg TV, and other platforms to raise awareness about the Company.    The campaign is scheduled to commence during the second half of October at a cost of USD$150,000 payable to RedChip.

No securities will be issued to RedChip as compensation. To the Company’s knowledge, RedChip (including its directors and officers) holds no securities of the Company and maintains an arm’s-length relationship.

Nasdaq Compliance Notification

The Company received a notification letter (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not currently in compliance with Nasdaq Listing Rule 5550(a)(2). This rule requires listed securities to maintain a minimum bid price of US$1.00 per share, and the Company’s common shares have closed below this threshold for 30 consecutive business days from September 4, 2026, to October 16, 2026.

The Notification Letter does not immediately affect the listing or trading of Foremost’s common shares on the Nasdaq Capital Market under the symbol “FMST.” In accordance with Nasdaq Listing Rule 5810(c)(3)(A), Foremost has been granted a 180-calendar day compliance period, ending on April 19, 2027, to regain compliance with the minimum bid price requirement. To achieve compliance, the closing bid price of the Company’s common shares must meet or exceed US$1.00 for a minimum of ten consecutive business days during this period.

If Foremost does not regain compliance by April 17, 2027, the Company may be eligible for an additional 180-calendar day grace period, provided it meets the continued listing requirement for market value of publicly held shares (US$1 million) and all other initial listing standards for the Nasdaq Capital Market, except for the bid price requirement. The Company would also need to notify Nasdaq of its plans to cure the deficiency.

Foremost’s management is evaluating all available options to address the bid price deficiency, including increased investor awareness, and remains committed to maintaining its Nasdaq listing. The Company’s business operations, financial condition, and corporate strategy are unaffected by this notification.   Foremost is disclosing this notification, as required by Nasdaq rules, within four business days of receipt.

Qualified Person

The technical content of this news release has been reviewed and approved by Cameron MacKay, P. Geo., Vice President of Exploration for Foremost Clean Energy Ltd., and a Qualified Person under National Instrument 43-101.

About Foremost

Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (WKN: A3DCC8) is a North American uranium, lithium, and gold exploration company strategically positioned to support the long-term growth in demand expected for reliable, carbon-free energy sources.

The Company has a portfolio of 10 property interests spanning over 330,000 acres in the prolific, uranium-rich Athabasca Basin region of northern Saskatchewan, including an option from Denison to earn up to a 70% interest in 8 prospective uranium properties (except for the Hatchet Lake, where Foremost can earn up to 51%), plus a minority ownership interest (20%) in the GR & Blackwing joint ventures with Denison.  

The Company’s uranium exploration efforts benefit from access to extensive historic drilling and geophysical data for targeting high-potential, mineralized trends. To date, Foremost has completed geophysical surveys and multiple drill campaigns that have generated encouraging results and defined high-priority exploration targets for follow-up drilling.

Foremost also has a portfolio of lithium-focused projects at varying stages of development spanning 43,000+ acres in Manitoba, providing exposure to other critical materials essential in electrification and energy storage.

For further information, please visit the Company’s website at www.foremostcleanenergy.com.

Contact and Information

David Cates, Interim CEO
[email protected]

Investor Relations

Dave Gentry
RedChip Companies, Inc.
1-407-644-4256
1-800-REDCHIP (733-2447)
[email protected] 

Follow us or contact us on social media:

X: @fmstcleanenergy
LinkedIn: https://www.linkedin.com/company/foremostcleanenergy  
Facebook: https://www.facebook.com/ForemostCleanEnergy

Forward-Looking Statements

Except for the statements of historical fact contained herein, the information presented in this news release and oral statements made from time to time by representatives of the Company are or may constitute “forward-looking statements” as such term is used in applicable United States and Canadian laws and including, without limitation, within the meaning of the Private Securities Litigation Reform Act of 1995, for which the Company claims the protection of the safe harbor for forward-looking statements. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any other statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects” or “does not expect,” “is expected,” “anticipates” or “does not anticipate,” “plans,” “estimates” or “intends,” or stating that certain actions, events or results “may,” “could,” “would,” “might” or “will” be taken, occur or be achieved) are not statements of historical fact and should be viewed as forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such risks and other factors include, among others, statements regarding: the completion of the Transaction and the timing thereof, including the sale of a 31% interest in each of the Properties, the formation of the joint ventures, entry into the A&R Option Agreement and the issuance of the Warrants; the receipt by the Company of total consideration of $650,000; the Company retaining a 20% interest in each of the Properties; Denison funding 80% of future expenditures and carrying out geophysical studies or making deficiency deposits to maintain the Properties until at least January 4, 2028; the expectation that Denison will carry out geophysical studies within the next 12 months and that such studies will further define the exploration potential of the Properties and generate future drill targets; the potential for the Properties to become a new area of exploration focus and the Company’s exposure to potential future exploration success; the Company’s election to fund its share of the Initial Expenditures or dilute its ownership interest; the exercise of the Warrants; the application of the Ownership Cap and any extension of the Term or purchase by the Company of Warrants not exercisable due to the Ownership Cap; the Company’s ability to complete Option Tranche 3 under the A&R Option Agreement, including completing $12.0 million in eligible exploration expenditures by July 9, 2029 and paying $2.5 million in additional consideration to Denison; the availability of information on SEDAR+; the timing, scope and cost of the marketing services and television campaign to be provided by RedChip; and the long-term growth in demand expected for carbon-free energy sources.

In making the forward-looking statements in this news release, the Company has applied several material assumptions, including, without limitation, that: the transactions with Denison will be completed on the terms and within the timeframes currently anticipated; all required approvals, including any approval of the Canadian Securities Exchange, will be obtained in a timely manner; Denison will perform its obligations under the joint venture agreements, the Warrants and the A&R Option Agreement; geophysical studies on the Properties will be carried out as expected and will yield results supporting further exploration; the Company will have access to sufficient capital, on acceptable terms, to fund its share of joint venture expenditures (if it so elects) and to satisfy the requirements of Option Tranche 3; the market price of the Company’s common shares will not change in a manner that adversely affects the Warrants or the Company’s obligations relating to the Ownership Cap; RedChip will deliver its services as scheduled and at the anticipated cost; there will be no material adverse change in uranium prices, general economic, market or industry conditions; and exploration and permitting activities will not be materially delayed by weather, regulatory or other factors.

Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release include, among others: the risk that the transactions with Denison are not completed on the anticipated terms or timeline, or at all; the failure to obtain any required regulatory or stock exchange approvals; the risk that Denison does not carry out geophysical studies or other expenditures on the Properties as anticipated, or that such studies do not identify drill targets or further define exploration potential; the inherent uncertainty of mineral exploration and the speculative nature of exploration-stage properties; the dilution of the Company’s interest in the joint ventures should it elect not to, or be unable to, fund its share of expenditures; the risk that the Company is required to purchase Warrants from Denison or that an extension of the Term is not approved; the potential dilution to shareholders resulting from the exercise of the Warrants; the Company’s inability to complete Option Tranche 3 or to fund the required expenditures and additional consideration under the A&R Option Agreement, and the consequences of any default thereunder; the availability of capital to fund programs and the resulting dilution caused by the raising of capital through the sale of shares; continuity of agreements with third parties, including Denison and RedChip; the effectiveness of the Company’s investor relations and marketing activities; fluctuations in uranium and other commodity prices and in the market price of the Company’s common shares; risks and uncertainties associated with the environment; and delays in obtaining governmental approvals, permits or financing. Additional factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company’s filings with the Securities and Exchange Commission.

Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved.

The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and in any document referred to in this news release. This news release shall not constitute an offer to sell or the solicitation of an offer to buy securities. and information. Please refer to the Company’s most recent filings under its profile at on Sedar+ at www.sedarplus.ca and on Edgar at www.sec.gov for further information respecting the risks affecting the Company and its business.

The CSE has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/83847915-25d3-4e93-8c23-170dd0e60c50



XAI Floating Rate & Alternative Income Trust Will Host its Q3 2026 Quarterly Webinar on November 2, 2026

CHICAGO, Oct. 22, 2026 (GLOBE NEWSWIRE) — XAI Floating Rate & Alternative Income Trust (NYSE: XFLT) (the “Trust”) today announced that it plans to host the Trust’s Quarterly Webinar on November 2, 2026, at 3:00 pm (Eastern Time). Kevin Davis, Managing Director at XA Investments will moderate the Q&A style webinar with Kimberly Flynn, President at XA Investments, and Young Choi, Partner and Global Head of Trading at King Street Capital Management. Young Choi also serves as the Portfolio Manager of Rockford Tower Capital Management, King Street’s CLO, CBO and SMA platform.

TO JOIN VIA WEB: Please click here to find the online registration link.

TO USE YOUR TELEPHONE: After joining via web, if you prefer to use your phone for audio, you must select that option and call in using a number below, based on your current location.

Dial: (312) 626-6799 or (646) 558-8656 or (267) 831-0333 or (720) 928-9299 or (213) 338-8477

Webinar ID: 830 6838 9008

REPLAY: A replay of the webinar will be available in the Knowledge Bank section of xainvestments.com.

The Trust’s common shares are traded on the New York Stock Exchange under the symbol “XFLT.” The investment objective of the Trust is to seek attractive total return with an emphasis on income generation across multiple stages of the credit cycle. The Trust seeks to achieve its investment objective by investing in a dynamically managed portfolio of opportunities primarily within the private credit markets. Under normal market conditions, the Trust will invest at least 80% of its Managed Assets in floating rate credit instruments and other structured credit investments. There can be no assurance that the Trust will achieve its investment objective.

About XA Investments

XA Investments LLC (“XA Investments”) is a Chicago-based firm founded by XMS Capital Partners in 2016. XA Investments serves as the investment adviser for two listed closed-end funds, an interval fund, and a tender offer fund. The listed closed-end funds, the XAI Floating Rate & Alternative Income Trust and XAI Madison Equity Premium Income Fund, both trade on the New York Stock Exchange and the interval fund and tender offer fund, XAI CLO & Income Opportunities Fund and Evanston Multi-Alpha Fund, are both available via direct subscription and through select broker/dealers and wealth management platforms.

In addition to investment advisory services, the firm also provides investment fund structuring and consulting services focused on registered closed-end funds to meet institutional client needs. XA Investments offers custom product build and consulting services, including product development and market research, marketing and fund management.

XA Investments believes that the investing public can benefit from new vehicles to access a broad range of alternative investment strategies and managers. XA Investments provides individual investors with access to institutional-caliber alternative managers. For more information, please visit www.xainvestments.com.

About XMS Capital Partners

XMS Capital Partners, LLC, established in 2006, is a global, independent, financial services firm providing M&A, corporate advisory and asset management services to clients. It has offices in Chicago, Boston and London. For more information, please visit www.xmscapital.com.

About Rockford Tower Asset Management

Rockford Tower Asset Management, L.L.C. is a wholly owned subsidiary of King Street Capital Management, L.P. (“King Street”) and an affiliate of Rockford Tower Capital Management (“Rockford Tower”). Rockford Tower, King Street’s dedicated CLO, CBO and SMA platform, was formed in 2017. Rockford Tower has over $14.7 billion of assets under management as of September 30, 2026, across 19 U.S. CLOs and 10 European CLOs, one CBO transaction and one SMA. In addition, Rockford Tower has traded over $99 billion of loans as of December 31, 2025.

About King Street Capital Management

King Street is a global alternative investment firm founded in 1995 that manages $30.9 billion in assets as of September 30, 2026 across public and private markets. The firm marries rigorous fundamental research with tactical trading and differentiated sourcing capabilities to identify investment opportunities across asset classes, up and down the capital structure. For more information, please visit www.kingstreet.com.

XA Investments does not provide tax advice; please consult a professional tax advisor regarding your specific tax situation. Income may be subject to state and local taxes, as well as the federal alternative minimum tax.

Investors should consider the investment objectives and policies, risk considerations, charges and expenses of the Trust carefully before investing. For more information on the Trust, please visit the Trust’s webpage at www.xainvestments.com.

This press release shall not constitute an offer to sell or a solicitation to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer or solicitation or sale would be unlawful prior to registration or qualification under the laws of such state or jurisdiction.

         
NOT FDIC INSURED        NO BANK GUARANTEE    MAY LOSE VALUE

Paralel Distributors, LLC – Distributor

Media Contact: 

Kimberly Flynn, President
XA Investments LLC
Phone: (312) 374-6931
Email: [email protected]
www.xainvestments.com



Namib Minerals Signs Indicative US$30 Million Ecobank Term Sheet for Redwing Bankability Programme

NEW YORK, Oct. 22, 2026 (GLOBE NEWSWIRE) — Namib Minerals (“Namib” or “the Company”) (Nasdaq: NAMM) today announced that its subsidiary, Bulawayo Mining Company (Private) Limited, has signed a nonbinding term sheet with Ecobank Zimbabwe Limited (“Ecobank”) for a proposed non-dilutive $30 million, 36-month loan facility (the “Proposed Facility”) intended to support Redwing Mine’s resource-definition and bankability programme. The Proposed Facility remains subject to completion of the customary conditions precedent and the execution of definitive documentation.

Upon completion of the definitive documentation and satisfaction of the customary conditions precedent, on the proposed terms, the Proposed Facility, together with previously secured funding allocated to the programme, is expected to provide the funding required to complete Step 3 of the Company’s Development Timelines and Milestones (“Development Milestones”), based on the programme’s current scope and budget. Step 3 focuses on resource definition and establishing the bankability of Redwing Mine.

As previously announced, Step 3 had been partly funded by the US$6.5 million non-dilutive term loan facility secured from African Banking Corporation of Zimbabwe Limited (“BancABC”). Under the term sheet, the Proposed Facility would finance hoist-related expenditures, expansion and maintenance of the milling plant, drilling equipment, mine development and further exploration drilling to increase Redwing Mine’s resource base.

Resource definition and bankability are key milestones in assessing the potential to develop Redwing Mine into a larger-scale gold operation. Completion of this programme will inform the proposed development’s scale, capital requirements and construction plan, and support the Company’s investment decision.

The Company intends to provide further updates on the status of the Proposed Facility and progress against the Development Milestones.

The term sheet also contemplates Ecobank and Ecobank Group acting as lead arranger and underwriter for financing the construction phase of Redwing’s proposed larger-scale development, following completion of the definitive feasibility study and subject to further conditions and arrangements. The Company intends to provide further details of the scope, amount and terms as they develop upon completion of the definitive feasibility study.

“Further to our announcement on 5 June 2026, we believe Ecobank’s continued support of the Company further reflects confidence in our resources and operating record. If completed on the proposed terms, this Facility would, subject to the results of the definitive feasibility study and negotiation of definitive documentation, complete the funding package for Redwing’s resource-definition and bankability programme. Our focus is on delivering this programme and establishing the basis for a disciplined construction decision,” said Sphe Mchunu, Chief Financial Officer of Namib Minerals.

About Namib Minerals

Namib Minerals (NASDAQ: NAMM) is a gold producer, developer and explorer with operations focused in Zimbabwe. Currently Namib Minerals operates the How Mine, an underground gold mine in Zimbabwe, and aims to restart two assets in Zimbabwe. For additional information, please visit namibminerals.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, statements regarding the Proposed Facility; the negotiation and execution of definitive financing documentation; the expected availability, sufficiency and deployment of proceeds from the Proposed Facility; the completion of Step 3 of the Company’s Development Milestones; the completion of resource-definition activities and feasibility studies at Redwing Mine; potential construction financing; the planned larger-scale development and restart of Redwing Mine; and the Company’s broader growth strategy. Forward-looking statements are typically identified by words such as “expects,” “intends,” “plans,” “targets,” “anticipates,” “believes,” “will,” “may” and similar expressions.

These statements are based on management’s current expectations and assumptions and are subject to significant risks and uncertainties, many of which are beyond the Company’s control, that could cause actual results to differ materially from those expressed or implied.

Forward-looking statements speak only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law. No assurance can be given that the Proposed Facility will be completed or funded, or that the development milestones, funding or production targets described in this press release will be achieved within the expected timeframes, or at all.

Contact:

Investor Relations:
[email protected]



GeoPark Announces Tender Results of Cash Tender Offer for Any and All of Its Outstanding 8.750% Senior Notes Due 2030 (CUSIP Nos. 37255B AC3; G38327 AD7 / ISIN US37255BAC37; USG38327AD78)

Bogotá, Colombia, Oct. 22, 2026 (GLOBE NEWSWIRE) — GeoPark Limited (“GeoPark” or the “Company”) (NYSE: GPRK), an exempted company incorporated under the laws of Bermuda, today announced the tender results in connection with its offer to purchase for cash any and all of its outstanding 8.750% Senior Notes due 2030 (the “Notes”) (the “Tender Offer”). The Tender Offer was made upon the terms and subject to the conditions (including the Financing Condition (as defined in the Offer to Purchase)) set forth in the offer to purchase dated October 16, 2026 (the “Offer to Purchase”).

As previously announced, the expiration time for the Tender Offer was 5:00 p.m., New York City time, on October 22, 2026 (such date and time, the “Expiration Time”). As of the Expiration Time, U.S.$ 266,832,000 in aggregate principal amount of the Notes outstanding had been validly tendered and not withdrawn pursuant to the Tender Offer. Settlement of the Tender Offer is expected to occur on or about October 28, 2026 (the “Settlement Date”).

The table below summarizes certain payment terms for the Notes:

Description of Security   CUSIP No.   ISIN   Outstanding Principal Amount as of the Date Hereof   Consideration per U.S.$1,000 Outstanding Principal Amount

(1)
  Aggregate Principal Amount Validly Tendered   Aggregate Principal Amount Outstanding After Giving Effect to Settlement of the Tender Offer
8.750% Senior Notes due 2030   144A: 37255B AC3
Reg S: G38327 AD7
  144A: US37255BAC37
Reg S: USG38327AD78
  U.S.$441,679,000   U.S.$1,027.50   266,832,000   174,847,000
         
(1) The Consideration for the Notes will be paid together with accrued and unpaid interest from the last interest payment date for the Notes up to, but not including, the Settlement Date.
 

Upon the terms and subject to the conditions of the Tender Offer set forth in the Offer to Purchase, all Notes validly tendered and not validly withdrawn at or prior to the Expiration Time, if accepted by GeoPark for purchase, will be paid in full by GeoPark on the Settlement Date and all Holders who validly tendered and did not validly withdraw their Notes at any time at or prior to the Expiration Time will receive the Consideration plus accrued and unpaid interest from the last interest payment date for the Notes to, but not including, the Settlement Date, at that time.

The obligation of GeoPark to purchase Notes in the Tender Offer is conditioned on the satisfaction or waiver of certain conditions, including, without limitation, the Financing Condition, described in the Offer to Purchase.

The information and tender agent for the Tender Offer is D.F. King & Co., Inc. Requests for documentation and questions regarding the Tender Offer can be directed to D.F. King & Co., Inc. at its telephone numbers (646) 582-2900 and (800) 967-5084, or by email at [email protected].

Copies of the Offer to Purchase are available from the tender offer website (the “Tender Offer Website”): www.dfking.com/geopark, subject to eligibility confirmation and registration.

Any questions or requests for assistance or for additional copies of this notice may be directed to the dealer managers at their respective telephone numbers set forth below or, if by any Holder, to such Holder’s broker, dealer, commercial bank, trust company or other nominee for assistance concerning the Tender Offer.

The dealer managers for the Tender Offer are:

Citigroup Global Markets Inc.

388 Greenwich Street, Trading
4th Floor
New York, NY 10013
United States
Attn: Liability Management Group
Deutsche Bank Securities Inc.

1 Columbus Circle
New York, NY 10019
United States
Attention: Liability Management Group
J.P. Morgan Securities LLC

270 Park Avenue
New York, New York 10017
United States
Attn: Latin America Debt
Capital Markets
     
Collect: +1 (212) 723-6106
Toll-Free: +1 (800) 558-3745
Collect: +1 (212) 250-2955
Toll-Free: +1 (866) 627-0391
Collect: +1 (212) 834-7279
Toll Free: +1 (866) 846-2874
     

This notice does not constitute or form part of any offer or invitation to purchase, or any solicitation of any offer to sell, the Notes or any other securities in the United States or any other country, nor shall it or any part of it, or the fact of its release, form the basis of, or be relied on or in connection with, any contract therefor. The Tender Offer is made only by and pursuant to the terms of the Offer to Purchase, and the information in this notice is qualified by reference to the Offer to Purchase. None of GeoPark, the dealer managers or the information and tender agent have made any recommendation as to whether Holders should tender their Notes pursuant to the Tender Offer.

For further information, please contact:

        
INVESTORS:

Maria Catalina Escobar
Shareholder Value and Capital Markets Director
[email protected]

Miguel Bello
Investor Relations Officer

[email protected]

Maria Alejandra Velez
Investor Relations Leader

[email protected]
   

MEDIA:

Communications Department [email protected]
   

CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often are preceded by words such as “believes,” “expects,” “may,” “anticipates,” “plans,” “intends,” “assumes,” “will” or similar expressions. The forward-looking statements contained herein include statements about the tender offer for the notes due 2030, the Company’s notes offering and its intended use of proceeds therefrom. These expectations may or may not be realized. Some of these expectations may be based upon assumptions or judgments that prove to be incorrect. In addition, GeoPark’s business and operations involve numerous risks and uncertainties, many of which are beyond the control of GeoPark, which could result in GeoPark’s expectations not being realized or otherwise materially affect the financial condition, results of operations and cash flows of GeoPark. Some of the factors that could cause future results to materially differ from recent results or those projected in forward-looking statements are described in GeoPark’s filings with the United States Securities and Exchange Commission.

The forward-looking statements are made only as of the date hereof, and GeoPark does not undertake any obligation to (and expressly disclaims any obligation to) update any forward-looking statements to reflect events or circumstances after the date such statements were made, or to reflect the occurrence of unanticipated events. In light of the risks and uncertainties described above, and the potential for variation of actual results from the assumptions on which certain of such forward-looking statements are based, investors should keep in mind that the results, events or developments disclosed in any forward-looking statement made in this document may not occur, and that actual results may vary materially from those described herein, including those described as anticipated, expected, targeted, projected or otherwise.



XAI Madison Equity Premium Income Fund Will Host its Q3 2026 Quarterly Webinar on November 5, 2026

CHICAGO, Oct. 22, 2026 (GLOBE NEWSWIRE) — XAI Madison Equity Premium Income Fund (NYSE: MCN) (the “Fund”) today announced that it plans to host the Fund’s Quarterly Webinar on November 5, 2026 at 11:00 am (Eastern Time). Kimberly Flynn, President at XA Investments will moderate the Q&A style webinar with Ray Di Bernardo and Drew Justman, Portfolio Managers at Madison Investments.

TO JOIN VIA WEB: Please click here to find the online registration link.

TO USE YOUR TELEPHONE: After joining via web, if you prefer to use your phone for audio, you must select that option and call in using a number below, based on your current location.

Dial: (312) 626-6799 or (646) 558-8656 or (267) 831-0333 or (720) 928-9299 or (213) 338-8477
Webinar ID: 832 1620 9414

REPLAY: A replay of the webinar will be available in the Knowledge Bank section of xainvestments.com.

The Fund’s primary investment objective is to provide a high level of current income and gains, with a secondary objective of capital appreciation. The Fund pursues its investment objectives by investing in a portfolio consisting primarily of high quality, large and mid-capitalization stocks that are, in the view of the Fund’s Investment sub-adviser, selling at a reasonable price in relation to their long-term earnings growth rates. The Fund will, on an ongoing and consistent basis, sell covered call options on its portfolio stocks to seek to generate current earnings from option premiums. There can be no assurance that the Fund will achieve its investment objectives. The Fund’s common shares are traded on the New York Stock Exchange under the symbol MCN.

About XA Investments

XA Investments LLC (“XA Investments”) is a Chicago-based firm founded by XMS Capital Partners in 2016. XA Investments serves as the investment adviser for two listed closed-end funds, an interval fund, and a tender offer fund. The listed closed-end funds, the XAI Floating Rate & Alternative Income Trust and XAI Madison Equity Premium Income Fund, both trade on the New York Stock Exchange and the interval fund and tender offer fund, XAI CLO & Income Opportunities Fund and Evanston Multi-Alpha Fund, are both available via direct subscription and through select broker/dealers and wealth management platforms.

In addition to investment advisory services, the firm also provides investment fund structuring and consulting services focused on registered closed-end funds to meet institutional client needs. XA Investments offers custom product build and consulting services, including product development and market research, marketing and fund management.

XA Investments believes that the investing public can benefit from new vehicles to access a broad range of alternative investment strategies and managers. XA Investments provides individual investors with access to institutional-caliber alternative managers. For more information, please visit www.xainvestments.com.

About XMS Capital Partners

XMS Capital Partners, LLC, established in 2006, is a global, independent, financial services firm providing M&A, corporate advisory and asset management services to clients. It has offices in Chicago, Boston and London. For more information, please visit www.xmscapital.com.

About Madison Investments

Madison Investments (Madison) is an independent investment management firm based in Madison, Wisconsin. The firm was founded in 1974, has approximately $29 billion in assets under management as of June 30, 2026, and is recognized as one of the nation’s top investment firms. The firm has managed covered call strategies for over 20 years through various market cycles. Madison offers domestic fixed income, U.S. and international equity, covered call, multi-asset, insurance, and credit union investment management strategies. For more information, please visit www.madisonfunds.com.

XA Investments does not provide tax advice; please consult a professional tax advisor regarding your specific tax situation. Income may be subject to state and local taxes, as well as the federal alternative minimum tax.

Investors should consider the investment objectives and policies, risk considerations, charges and expenses of the Trust carefully before investing. For more information on the Trust, please visit the Trust’s webpage at www.xainvestments.com.

This press release shall not constitute an offer to sell or a solicitation to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer or solicitation or sale would be unlawful prior to registration or qualification under the laws of such state or jurisdiction.

         
NOT FDIC INSURED   NO BANK GUARANTEE   MAY LOSE VALUE

Paralel Distributors, LLC – Distributor

Media Contact: 

Kimberly Flynn, President
XA Investments LLC
Phone: (312) 374-6931
Email: [email protected]
www.xainvestments.com